Monopar Therapeutics Inc (MNPR)
0.62
+0.01
(+0.88%)
USD |
NASDAQ |
May 23, 16:00
0.62
0.00 (0.00%)
After-Hours: 20:00
Monopar Therapeutics Cash from Investing (TTM): 4.928M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 4.928M |
| December 31, 2023 | 4.928M |
| September 30, 2023 | -2.961M |
| Date | Value |
|---|---|
| June 30, 2023 | -2.948M |
| March 31, 2023 | -5.902M |
| December 31, 2022 | -4.918M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-5.902M
Minimum
Mar 2023
4.928M
Maximum
Mar 2024
-1.146M
Average
-2.955M
Median
Cash from Investing (TTM) Benchmarks
| Motus GI Holdings Inc | -0.065M |
| SeaStar Medical Holding Corp | -- |
| Perspective Therapeutics Inc | -48.19M |
| Electromed Inc | -0.79M |
| Xtant Medical Holdings Inc | -8.037M |